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Background: We determined the accuracy of Rubarth’s newborn scale of sepsis and C- reactive protein in diagnosing
neonatal sepsis and assessed antimicrobial susceptibility pattern of etiological bacteria.
Methods: This cross sectional study was conducted at Muhimbili National Hospital in Dar es Salaam, Tanzania between
July 2012 and March 2013. Neonates suspected to have sepsis underwent physical examination using Rubarth’s
newborn scale of sepsis (RNSOS). Blood was taken for culture and antimicrobial sensitivity testing, full blood picture
and C – reactive protein (CRP) performed 12 hours apart. The efficacy of RNSOS and serial CRP was assessed by
calculating sensitivity, specificity, negative and positive predictive values, receiver operating characteristics (ROC)
analysis as well as likelihood ratios (LHR) with blood culture result used as a gold standard.
Results: Out of 208 blood samples, 19.2% had a positive blood culture. Single CRP had sensitivity and specificity of
87.5% and 70.9% respectively, while RNSOS had sensitivity of 65% and specificity of 79.7%. Serial CRP had sensitivity of
69.0% and specificity of 92.9%. Combination of CRP and RNSOS increased sensitivity to 95.6% and specificity of 56.4%.
Combination of two CRP and RNSOS decreased sensitivity to 89.1% but increased specificity to 74%. ROC for CRP was
0.86; and for RNSOS was 0.81.
For CRP the LHR for positive test was 3 while for negative test was 0.18, while for RNSOS the corresponding values
were 3.24 and for negative test was 0.43.
Isolated bacteria were Klebsiella spp 14 (35%), Escherichia coli 12 (22.5%), Coagulase negative staphlococci 9 (30%),
Staphylococcus aureus 4 (10%), and Pseudomonas spp 1 (2.5%). The overall resistance to the WHO recommended
first line antibiotics was 100%, 92% and 42% for cloxacillin, ampicillin and gentamicin, respectively. For the second
line drugs resistance was 45%, 40%, and 7% for ceftriaxone, vancomycin and amikacin respectively.
Conclusions: Single CRP in combination with RNSOS can be used for rapid identification of neonates with sepsis
due to high sensitivity (95.6%) but cannot exclude those without sepsis due to low specificity (56.4%). Serial CRP
done 12hrs apart can be used to exclude non-cases. This study demonstrated very high levels of resistance to the
first-line antibiotics.
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Adequate and timely diagnosis of neonatal sepsis re-
mains an important challenge to the clinician especially
in developing countries [1]. Blood culture, which is the
gold standard for definitive diagnosis, takes at least 48
hours up to 6 days [2], by which time the infection may
have progressed with consequences on the morbidity
and mortality of the neonates [1,2].
Inflammatory markers such as procalcitonin, C –
reactive proteins (CRP) and haematological indices have
also been used in diagnosing neonatal sepsis [3-7].
The advantage of CRP includes its very low serum
level in normal infants and rapid rise within 6 to 8 hours
after the onset of sepsis [5,7-10]. Previous studies have
shown that quantitative serial CRP levels 12 – 24 hours
offer the most sensitive and reliable information [10-12].
And can therefore be used as an adjuvant tool to guide
physicians [11,13,14].
Haematological scoring system (HSS) based on FBP,
total leukocyte count, neutrophils and platelets have also
been used to predict neonatal sepsis [3,7].
In resource limited settings, where blood culture is not
routinely done, relatively inexpensive screening tools such
as CRP and HSS can be utilized as a screening tools, po-
tentially serving lives [6].
An additional challenge in the management of neo-
natal sepsis in most developing countries is a reliance on
empirical use of antibiotics based on a recommended list
of antibiotics, which are increasingly become ineffective
owing to growing antimicrobial resistance [15-18].
In a bid to improve the management of neonatal sepsis
at Muhimbili National Hospital, Dar es Salaam, we set
to determine the efficacy of serial C – reactive protein
taken 12 hours apart and newborn scale of sepsis as
screening tools and antimicrobial susceptibility patterns
of the etiological agents.
Methods
Study setting, design and participants
This was a prospective cross sectional study conducted at
Muhimbili National Hospital (MNH) neonatal unit be-
tween July 2012 and March 2013. MNH is the National
Referral Hospital and University Teaching Hospital with
neonatal unit admitting an average of 20 neonates a day.
A total of 208 neonates who met the WHO case definition
for neonatal sepsis [19] were recruited consecutively. The
sample size was determined using Epi info version 6.0
based on the prevalence of blood stream infection of
13.9% found by Bloomberg et al. [16] in the same hospital.
Inclusion criteria
A neonate who met clinical criteria by WHO case defin-
ition for septicemia [1] was included. The clinical defin-
ition included any one of the following features History of difficulty feeding
 History of convulsions
 Movement only when stimulated
 Respiratory rate ≥60 breaths per minute
 Severe chest indrawing.
 Axillary temperature ≥37.5°C
 Axillary temperature ≤35.5°C
 Bulging anterior fontanelle,
 Signs of infection on the skin with pus spots and
umbilicus pus spots
Exclusion criteria
 Unwillingness of the parent or guardian to participate
in the study
 Very sick children in decompensate state and
requiring resuscitation
 Neonates with severe congenital malformation such
as anencephaly
Clinical assessment and laboratory investigations
Rubarth’s newborn scale of sepsis
This tool has two parts [19]. The first part includes
physical examination of the patient has eight parameters
with a total score of 35 points. The second part includes
five laboratory parameters with a total score of 20
points. The total score from both parameters is 55. A
neonate a total score of 10 or more, was considered to
have sepsis.
Collection of blood samples
About 3.5 mls of venous blood was aseptically drawn
from peripheral vein. Two mls were inoculated into
Bacteralert paediatric blood culture bottle (BacT/Alert
PF (Organon-Teknika Corp., Durham, N.C.). Another
1ml was used for measurement of CRP while 0.5 mls
was used for full blood picture. About twelve hours later
another 1 ml of blood was collected for a second CRP
determination.
Full blood picture
For determination of full blood picture, blood samples
were collected in vacutainers containing EDTA (Ethylene
diamine tetra-acetic acid) and analysed by CELLDYNE
3700 (Abbott Laboratories. Abbott Park, Illinois, U.S.A.).
Normal ranges were taken to be between 5000 and
30,000/ml for WBC, 1000 and 2000 for neutrophils,
150,000 and 450,000/ml for platelets. The extreme value
on either side was suggestive of ongoing neonatal sepsis.
CRP determination
To determine CRP blood samples were centrifuged for
separation of the serum within 60 minutes of blood collec-
tion and analysis was performed using COBRA 400/400
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value of more than 5 mg/l was considered to be associated
with sepsis.Blood culture
Blood culture bottles were incubated at 37°C temperature
for 24 h after which aliquots were sub-cultured on solid
agar plates; blood agar (Oxoid, UK) and MacConkey agar
(Oxoid, UK) and chocolate agars (Oxoid, UK) for up 96
hours before being regarded as having no growth. Identifi-
cation was based on microscopic characteristics, colonial
characteristics, and Biochemical tests as described by
Murray et al. [20], including VITEX (BioMerieux, France)
and API 20E (BioMerieux, France). Gram negative organ-
isms were identified by oxidase, Triple sugar Iron (TSI),
sulphur indole and motility (SIM), urease, citrate test, VP
and Methyl red test. Whereas Gram positive organisms
were catalase reaction, coagulase test, DNase test and bile
esculin test [20].Table 1 Baseline demographic characteristics of the
neonates enrolled in the studyAntimicrobial sensitivity testing
Antimicrobial susceptibility of isolates was determined
using disk diffusion method according to Clinical
Laboratory standard Institute [21]. Sensitivity testing
was performed for antimicrobials which included ampicil-
lin, cloxacillin and gentamicin which are used as first line
antibiotics and ceftriaxone and vancomycin and amikacin
which are used as second line drugs for treatment of neo-
natal sepsis at MNH. The concentration of the disks were
as follows; ampicillin 10 μg, cloxacillin 5 μg gentamicin
10 μg, ceftriaxone 30 μg, amikacin 30 μg, vancomycin
30 μg. Results were recorded as resistant, intermediate
and sensitive. During data analysis isolates showing inter-
mediate resistance were categorized as being resistant.N = 208 Frequency (%)
Age group
0 – 3 109 52.9






1 – 1.4 10 4.81
1.5 – 2.5 26 12.5Statistical analysis
Statistical Package for Social Sciences (SPSS) version 17
was used for data entering, cleaning and analysis. Sensitiv-
ity, specificity, likelihood ratios of CRP and the Rubarth’s
newborn scale were calculated using blood culture as Gold
standard. Receiver operating characteristics (ROC curve)
analysis was used to determine the cut off points for both
Rubarth’s neonatal scale score and CRPs. The areas under
the curves (AUC) were established and the difference
between them was used to determine the better test. A
p value of <0.05 was considered statistically significant.>2.5 170 81.7
Clinical features
Fever 147 67.3
Low muscle tone 81 38.9
Fast breathing 166 79.8Ethical consideration
The ethics committee of the Muhimbili University of
Health and Allied Sciences (MUHAS) approved the study.
Informed written consents were obtained from parents/
guardian prior to recruitment.Results
Baseline characteristics
A total of 208 neonates were enrolled in this study, of
whom 108 (51.9%) were male babies. Their median age
was 5.6 days (1 – 28 days), and more than half (52.9%)
were ≤4 days, and majority (81.7%) weighed ≥2.5 kg.
Upon examination 67.3% of the participants had fever,
38.9% low muscle tone, and 79.8% were found to have
fast breathing (Table 1).
Isolated bacterial pathogens
A positive blood culture was found in 40 (19.2%) of the 208
blood samples. The bacteria isolated included Klebsiella spp
14 (35%), E. coli 12 (22.5%), CoNS 9 (30%), S.aureas 4 (10%),
and Pseudomonas aeroginosa 1 (2.5%) (Figure 1).
Antimicrobial sensitivity pattern of the isolated bacteria
The overall resistance of isolated organisms to the rec-
ommended first line antibiotics for ampicillin was 92%,
100% to cloxacillin while gentamicin had moderate re-
sistance of 42%. For the recommended second line anti-
biotics was 45% for ceftriaxone, 40% for vancomycin and
7% for amikacin (Figure 2).
Rubarth’s neonatal scale of sepsis
RNSOS could identify 26 (65%) out of 40 neonates with
positive blood cultures, while 79.8% of the 168 patients
who had no growth on blood culture were correctly ex-
cluded by the test.
The likelihood ratio of the positive test was 3.24 and






Figure 1 Distribution of the isolated bacterial pathogens Figure 2:
Overall percentage resistance of isolated organisms to the
recommended drugs.
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First CRP
The first sample for CRP was positive in 35 (87.5%) out
of 40 samples which had a positive blood culture and
negative in 119 (70.8%) out of 168 samples with negative
blood culture. The positive predictive value was 41.7%
while negative predictive value was 95.9%. Likelihood ra-
tio for positive test was 3 while for negative test was
0.18 (Table 2).
Second CRP
Blood for the second sample for CRP (CRP2) was col-
lected from all babies except for four who died before a
sample was taken. CRP2 was positive in 30 (78.9%) out
of 38 blood samples with a positive blood culture and
was negative in 125 (75.3%) out of 166 blood samples
with no bacterial growth. The positive predictive value
of CRP2 was 42.3% while its negative predictive value






Figure 2 Overall percentage resistance of isolated organisms to
the recommended drugs.Effect of combination of tests
Serial CRP had sensitivity of 69.0% and specificity of
92.9%. Combination of first CRP and RNOS had sensi-
tivity of 95.6% while overall specificity decreased to
56.4%, while serial CRP and neonatal scale of sepsis had
sensitivity of 89.1% and specificity was found to be 74.0%
(Table 2).
Receiver Operating Characteristics (ROC) analysis curve
ROC analysis showed the following areas under the
curve in determining septicaemia in neonates for CRP1
(AUC = 0.86; 95% CI: 0.78, 0.93) for CRP2 (AUC = 0.88;
95% CI: 0.80, 0.95) and for RNSOS vs. AUC = 0.81; 95%
CI: 0.73, 0.88) (Figure 3). At optimal cut-off points for
both CRP1 and CRP2 gave higher sensitivities than that
of Rubarth’s scale (82.5% at the cut-off point 9 and
81.1% at the cut-off point 10 vs. 65% at cut-off point 10)
(Figure 3).
Discussion
We found a single CRP and RNSOS to have a very good
sensitivity (96.0%) in identifying neonates with sepsis but
had relatively low specificity (56.4%) in excluding non-
cases. The positive and negative predictive values and
likelihood ratio were also statistically significant showing
the ability of the test to identity cases from suspected
patients with neonatal sepsis.
Higher values are observed with quantitative analysis
than qualitative CRP, and the range has been shown to be
between 75 – 100% as demonstrated by studies done in
Kenya by Kumar et al. [12], Ogunlesi et al. [22], west el al.
[23] and Bomela et al. [13] in South Africa. Worth noting
is the ROC analysis, the AUC for both test was very close
to one encouragingly their use in resource poor settings
where blood culture can not be done routinely. This find-
ing has two implications; i) neonates with sepsis can
quickly be identified and immediately started on treatment
and thereby potentially reducing morbidity and mortality
and ii) reduce unnecessary prescription of antibiotics and
emergency of antibiotic resistance.
Based on our results we are suggesting a second CRP
should be performed on neonates not picked by a com-
bination of CRP and RNOS to exclude non-cases, and
thus minimize the unnecessary antibiotics, and even
those started treatment empirically can be stopped from
antibiotic used [24,25].
We also found that the Rubarth’s score, which com-
bines haematological parameters and physical parame-
ters, had moderate sensitivity (79.7%) and specificity
(65%) compared to when it was originally validated [21].
However when assessing the performance of individual
parameters, leukopenia and thrombocytopenia were
highly associated with sepsis thus indicating its useful-
ness in the diagnosis of sepsis.
Table 2 Sensitivity, specificity, predictive values and likelihood ratios of CRP and RNSOS as a single test and when in
combination
Sensitivity (C.I) Specificity (C.I) PPV (C.I) NPV (C.I) LHR + ve test
(C.I)
LHR - ve test
(C.I)
P value
RNSOS 65% (48 – 79.4) 79.7% (72.9 – 85.5) 43.3% (30.6 – 56.8) 90.5% (84.6 – 94.7) 3.24 (2.2 – 4.68) 0.45 (0.28 – 0.64) <0.01
CRP1 87.5% (73.25 – 95.81) 70.8% (63.3 – 77.58) 41.7% (31 – 52.97) 95.9% (90.84 – 98.68) 3 (2.3 – 3.9) 0.18 (0.08 – 0.4) <0.01
CRP2 78.9% (62.7 – 90.5) 75.8% (68 – 81.7) 42.3% (30.6 – 64.6) 93.9% (88.5 – 97.3) 3.2 (2.3 – 4.3) 0.27 (0.15 – 4.3) <0.01
CRP1 + CRP2 75.7% (58.8 – 88.2) 92.9% (87.9 – 96.2) 70% (53.4 – 83.4) 94.5 (89.9 – 97.4) 10.6 (4.1 – 17.1) 0.26 (0.10 – 0.42) <0.01
RNSOS + CRP1 95.6% (90.0 – 97.5) 56.4% (38.7 – 70.7) 71% (51.9 – 85.7) 89.8 (84.4 – 93.8) 10.3 (2.7 –17.8) 0.47 (0.3 – 0.65) 0.01
RNSOS + serial
CRP
47.5% (31.5 – 63.8) 96.4% (92.4 – 98.7) 76% (54.8 – 92.7) 88.5% (83 – 92.7) 13.3 (1.3 – 25.3) 0.54 (0.37 – 0.72) 0.03
C.I- confidence interval, CRP - C- reactive protein, RNSOS - Rubarth’s newborn scale of sepsis, PPV - Positive predictive value, NPV -negative predictive value,
LHR - likelihood ratio.
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higher sensitivity than when RNSOS was used alone.
Similar findings have been shown by Garland et al. [5]
and Hengst et al. [4]. However Manucha et al. in India
[6] concluded there was no advantage of combing
hematological test with CRP in the management of neo-
natal sepsis. The controversy in findings can be due to
the haematological score which was used. The added
value demonstrated by our study can be because our
scoring tool also assessed clinical presentation of the
neonates.
From this study combination of the two tests have
been proven to be effective and hence can be used for
screening suspected cases of neonatal sepsis. Fortunately
at MNH, FBP unlike blood culture, is done routinelyFigure 3 ROC curve analysis for CRP1, CRP2 and RNSOS. ROC – receive
newborn scale of sepsis.and RNSOS which is inexpensive can be introduced. In
a remote areas where some of the parameters of the
RNSOS can not be done, using the ROC curve analysis
has shown that CRP as either a single test or done seri-
ally has a better performance than RNSOS. The cost to
process CRP sample at the time of study was an equiva-
lent of approximately $10, compared to almost three
times the cost to process blood culture excluding high
level of expertise required for culture and sensitivity
processing.
Proven neonatal sepsis by blood culture was found in
only 19.2% of the neonates, which is in keeping with the
findings of Bloomberg et al. in 2005 [16] and Mhada et al.
in 2012 [15] at the same setting. The etiological agents
that we found; Klebsiella spp, E. coli, CoNS, S. aureus andr operating characteristic, CRP – C- reactive protein, RNSOS – Rubarth’s
Table 3 Trends of resistance to antibiotics used in
management of neonatal sepsis






Ampicillin 17% 88.2% 92%
Cloxacillin 12.5% 85.2% 100%
Gentamicin 37% 58.8% 42%
Ceftriaxone Not done 16.2% 45%
Cefuroxime 17.6% 20.6% Not done
Amikacin Not done 1.5% 7%
Vancomycin Not done Not done 40%
*Included other paediatrics patients, out of which were 170 neonates.
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leagues [25-28], with minor variations.
The improper use of antibiotics maybe responsible for
the very high levels of antibiotic resistance observed in
this and previous studies conducted at this hospital
[26,27]. Indeed, we found very high levels of resistance
to the first line antibiotics, ampicillin and cloxaccilin in
the range of 92 to 100%, with moderate resistance to
gentamicin and ceftriaxone. The moderate resistance to
ceftriaxone is due to its less frequent prescription since
it is a second line drug and its relatively high cost com-
pared to the first line antibiotics. Analysis of studies
which were conducted between 1999 and 2012 at MNH
and Bugando in Tanzania [15-18] has shown a gradual
increase on the resistance not only with the recom-
mended first line antibiotics but also to the alternative
antibiotics vancomycin and amikacin. In this study how-
ever, we are seeing an alarming increase of resistance to
amikacin when compared with the studies done by
Bloomberg et al. [26] and in 2012 by Mhada et al. in the
same setting [Table 3].
The very high levels of resistance to the WHO recom-
mended first line antibiotics have also been reported in
other parts of the world. In Pakistan resistance levels as
high as 100% to almost all the WHO recommended first
line treatment, leading to a change of their treatment
protocol [29].Conclusions
This study found that single CRP in combination with
Rubarth’s neonatal scale of sepsis has a high sensitivity
of 96.0% to screen for neonatal sepsis and serial CRP to
be useful for excluding non-cases. We found out that
only 19.2% of the neonates suspected of having sepsis
actually required antibiotics. We speculate that excessive
and unnecessary use of antibiotics has resulted in the
very high levels of antibiotic resistance. We are advo-
cating for the use of the inexpensive screening tools and
for a change of the currently prescribed antibioticsCompeting interests
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